Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Dajun_Yang
|
| gptkbp:focusesOn |
oncology
hematology age-related diseases apoptosis-targeted therapies |
| gptkbp:foundedIn |
2009
|
| gptkbp:founder |
gptkb:Dajun_Yang
|
| gptkbp:headquartersLocation |
gptkb:Suzhou,_China
gptkb:Rockville,_Maryland,_United_States |
| https://www.w3.org/2000/01/rdf-schema#label |
Ascentage Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedOn |
gptkb:Hong_Kong_Stock_Exchange
|
| gptkbp:notableProduct |
gptkb:APG-115_(MDM2-p53_inhibitor)
gptkb:APG-1252_(Bcl-2/Bcl-xL_inhibitor) gptkb:APG-2575_(Bcl-2_inhibitor) |
| gptkbp:operatesIn |
gptkb:China
gptkb:United_States |
| gptkbp:stockExchange |
gptkb:Hong_Kong_Stock_Exchange
|
| gptkbp:stockSymbol |
gptkb:6855.HK
|
| gptkbp:website |
https://www.ascentagepharma.com/
|
| gptkbp:bfsParent |
gptkb:Zhangjiang
|
| gptkbp:bfsLayer |
6
|